36
Views
6
CrossRef citations to date
0
Altmetric
Review

Development of DNA polymerase IIIC inhibitors for the treatment of Gram-positive bacterial infections

&
Pages 947-953 | Published online: 04 Aug 2005

Bibliography

  • BROWN NC, HANDSCHUMACHER RE: Inhibition of the synthesis of deoxyribonucleic acid in bacteria by 6-(p-hydroxyphenylazo)-2,4-dihydroxypyrimidine. j Biol. Chem. (1966) 241(13):3083–3089.
  • BROWN NC: Inhibition of bacterial DNA replication by 6-(p-hydroxyphenylazo)-uracil: differential effect on repair and semi-conservative synthesis in Bacillus subtilis. J. Mol. Biol. (1971) 59(1):1–16.
  • NEVILLE MM, BROWN NC: Inhibition of a discrete bacterial DNA polymerase by -hydroxyphenylazo)-uracil and 6-hydroxyphenylazo)-isocytosine. Nat. New Biol. (1972) 240(98):80–82.
  • •Elucidation of the role of polymerase III in DNA replication.
  • BAZILL GW, GROSS, JD: Effect of 64-hydroxyphenyfi-azouracil on B. subtilis DNA polymerases. Nat. New Biol. (1972) 240(98):82–83.
  • COZZARELLI NR, LOW RL: Mutational alteration of Bacillus subtilis DNA polymerase III to hydroxyphenylazopyrimidine resistance: polymerase III is necessary for DNA replication. Biochem. Biophys. Res. Commun. (1973) 51(1):151–157.
  • GASS KB, COZZARELLI NR: Further genetic and enzymological characterization of the three Bacillus subtilis deoxyribonucleic acid polymerases. J. Biol. Chem. (1973) 248(22):7688–7700.
  • MACKENZIE JM, NEVILLE MM, WRIGHT GE, BROWN NC: Hydroxyphenylazopyrimidines: characterization of the active forms and their inhibitory action on a DNA polymerase from Bacillus subtilis. Proc. Nail. Acad. Sci. USA (1973) 70(2):512–516.
  • •First mechanistic proposal involving hydrogen bonding of inhibitors with DNA base pairs.
  • GASS KB, LOW RI,, COZZARELLI NR: Inhibition of a DNA polymerase from Bacillus subtilis by hydroxyphenylazopyrimidines. Proc. Nail. Acad. Sci. USA (1973) 70(1):103–107.
  • WRIGHT GE, BROWN NC: Synthesis of 6-(phenylhydrazino)uracils and their inhibition of a replication-specific deoxyribonucleic acid polymerase. J. Med. Chem. (1974) 17(12):1277–1282.
  • LOW RI,, RASHBAUM SA, COZZARELLI NR: Mechanism of inhibition of Bacillus subtilis DNA polymerase III by the arylhydrazinopyrimidine antimicrobial agents. Proc. Natl. Acad. Sci. USA (1974) 71(8):2973–2977. 952Expert Opin. Ther Patents (2005) 15(8)
  • CLEMENTS JE, D'AMBROSIO J, BROWN NC: Inhibition of Bacillus subtilis deoxyribonucleic acid polymerase III by phenylhydrazinopyrimidines. j Biol. Chem. (1975) 250(2):522–526.
  • WRIGHT GE, BARIL EF, BROWN NC: Butylanilinouracil: a selective inhibitor of HeLa cell DNA synthesis and HeLa cell DNA polymerase a. Nud Acids Res. (1980) 8(1):99–109.
  • WRIGHT GE, BROWN NC: Inhibitors of Bacillus subtilis DNA polymerase III. Structure-activity relationships of 6-(phenylhydrazino)uracils. J. Med. Chem. (1977) 20(9):1181–1185.
  • COULTER CL, COZZARELLI NR: Crystal structure of an inhibitor and a model for inhibition of replicative DNA synthesis. Mol Bia (1975) 91(3):329–344.
  • WRIGHT GE, DUDYCZ LW: Synthesis and characterization of N2-(p-n-butylpheny1)-2'-deoxyguanosine and its 5'-triphosphate and their inhibition of HeLa DNA polymerase a. J. Med. Chem. (1984) 27(2):175–181.
  • WRIGHT GE, BROWN NC: Inhibition of Bacillus subtilis DNA polymerase III by arylhydrazinopyrimidines. Novel properties of 2-thiouracil derivatives. Biochim. Biophys. Acta. (1976) 432(1):37–48.
  • BROWN NC, WRIGHT GE: Inhibitors of bacterial DNA polymerases. Pharmac. Ther. A. (1977) 1:437–456.
  • •A review with 65 references of inhibitors of bacterial DNA polymerases I, II, and III.
  • BROWN NC, GAMBINO J, WRIGHT GE: Inhibitors of Bacillus subtilis DNA polymerase III. 6-(Arylalkylamino)uracils and 6-anilinouracils. J. Med. Chem. (1977) 20(9):1186–1189.
  • WRIGHT GE, BROWN, NC: Inhibitors of Bacillus subtilis DNA polymerase III. 6-Anilinouracils and 6-(alkylamino)uracils. J. Med. Chem. (1980) 23(1):34–38.
  • WRIGHT GE, BARIL EF, BROWN VM, BROWN NC: Design and characterization of N2-arylaminopurines which selectively inhibit replicative DNA synthesis and replication-specific DNA polymerases: guanine derivatives active on mammalian DNA polymerase alpha and bacterial DNA polymerase III. Nucl. Acids Res. (1982) 10(14):4431 4440.
  • WRIGHT GE, GAMBINO JJ: Quantitative structure-activity relationships of 6-anilinouracils as inhibitors of Bacillus subtilis DNA polymerase III. J. Med. Chem. (1984) 27(2):181–185.
  • TRANTOLO DJ, WRIGHT GE, BROWN NC: Inhibitors of Bacillus subtilis DNA polymerase III. Influence of modifications in the pyrimidine ring of anilino- and (benzylamino)pyrimidines. J. Med. Chem. (1986) 29(5):676–681.
  • BROWN NC, DUDYCZ LW WRIGHT GE: Rational design of substrate analogues targeted to selectively inhibit replication-specific DNA polymerases. Drugs ExptL Clin. Res. (1986) XII(6/7):555–564.
  • •A review of inhibitor mechanism.
  • ABDUL-AHAD PG, WEBB GA: A molecular orbital study of the electronic structure of some 6-substituted uracils. Bull. Chem. Soc. Jpn. (1987) 60(3):1125–1128.
  • BUTLER MM, DUDYCZ LW KHAN NN, WRIGHT GE, BROWN NC: Development of novel inhibitor probes of DNA polymerase III based on dGTP analogs of the HPUra type: base, nucleoside and nucleotide derivatives ofN2-(3,4-dichlorobenzyl)guanine. Nua Acids Res. (1990) 18(24):7381–7389.
  • WRIGHT GE, BROWN NC: Deoxyribonucleotide analogs as inhibitors and substrates of DNA polymerases. Pharmac. Ther. (1990) 47:447–497.
  • BUTLER M, DUDYCZ LW, KHAN NN, WRIGHT GE, BROWN NC: Novel inhibitor-probes of DNA polymerase III based on dGTP analogues of the H2•FIPUra type: redesign of the inhibitor structure using an N2-benzylguanine format. Nucleosides Nucleotides. (1991) 10(1-3):501–502.
  • TARANTINO PM, ZHI C, GAMBINO JJ, WRIGHT GE, BROWN NC: 6-Anilinouracil-based inhibitors of Bacillus subtilis DNA polymerase III: antipolymerase and antimicrobial structure-activity relationships based on substitution at uracil N3. J. Med. Chem. (1999) 42(10:2035–2040.
  • TARANTINO PM, ZHI C, WRIGHT GE, BROWN NC: Inhibitors of DNA polymerase III as novel antimicrobial agents against Gram-positive eubacteria. Anitmicrob. Agents Chemother. (1999) 43(8): 1982–1987.
  • •Discussion of 6-anilinouracil N3 alkyl substitution: effect on solubility and antimicrobial activity.
  • DALY JS, GIEHL TJ, BROWN NC, ZHI C, WRIGHT GE, ELLISON RT: In vitro antimicrobial activities of novel anilinouracils which selectively inhibit DNA polymerase III of Gram-positive bacteria. Anti microb. Agents Chemother. (2000) 44(8):2217–2221.
  • ZHI C, LONG Z-Y, GAMBINO J et al: Synthesis of substituted 6-anilinouracils and their inhibition of DNA polymerase IIIC and Gram-positive bacterial growth./ Med. Chem. (2003) 46(13):2731–2739.
  • ALI A. ASTER SD, GRAHAM DW et al.: Design and synthesis of novel antibacterial agents with inhibitory activity against DNA polymerase III. Bioorg-. Med. Chem. Lett. (2001) 11(16):2185–2188.
  • ALI A, TAYLOR GE, ELLSWORTH K et al.: Novel pyrazolo13,4-d1 pyrimidine-based inhibitors of Staphylococcus aureus DNA polymerase III: design, synthesis, and biological evaluation. J. Med. Chem. (2003) 46(10):1824–1830.
  • BARNES MH, MILLER SD, BROWN NC: DNA polymerases of low-GC Gram-positive eubacteria: identification of the replication-specific enzyme encoded by dnaE J. Bacteria (2002) 184(14)3834–3838.
  • ••Revised nomenclature and characterisationfor the replication-specific polymerases.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.